Breast Cancer Clinical Trials in L'Hospitalet de Llobregat, Barcelona
7 recruitingL'Hospitalet de Llobregat, Barcelona, Spain
Showing 1–7 of 7 trials
Recruiting
Not Applicable
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
Breast CancerRadiotherapy Side EffectSentinel Lymph Node+2 more
Hospital Universitari de Bellvitge820 enrolled59 locationsNCT04889924
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Hoffmann-La Roche450 enrolled210 locationsNCT06790693
Recruiting
Phase 1Phase 2
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
Breast Cancer
Novartis Pharmaceuticals58 enrolled32 locationsNCT06247995
Recruiting
TAD After Chemotherapy in Locally Advanced Breast Cancer
Breast CancerSentinel Lymph NodeLocally Advanced
Hospital Universitari de Bellvitge162 enrolled2 locationsNCT05763641
Recruiting
Not Applicable
Impact of Systematic Shaving on Margins
Breast CancerMargin, Tumor-FreeSurgery
Hospital Universitari de Bellvitge234 enrolled1 locationNCT05782686
Recruiting
Phase 1
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Breast Cancer
Novartis Pharmaceuticals48 enrolled25 locationsNCT05870579
Recruiting
ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy
Breast CancerAxillary Metastases
Hospital Universitari de Bellvitge43 enrolled1 locationNCT06339658